Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Epstein-Barr Encephalitis in a Child with Congenital Human Immunodeficiency Virus Infection: a Case Report Calling for No Forgetfulness.

Tsiatsiou O, Papachristou S, Papadimitriou E, Michailidou E, Chatzidimitriou D, Papa A, Doulioglou V, Karyda S, Antachopoulos C, Roilides E.

Curr HIV Res. 2019 Oct 16. doi: 10.2174/1570162X17666191017101223. [Epub ahead of print]

PMID:
31644409
2.

Thiamine Deficiency in a Child with Short Bowel Syndrome and Review.

Roilides I, Vasilaki K, Xinias I, Iosifidis E, Antachopoulos C, Roilides E.

Pediatr Gastroenterol Hepatol Nutr. 2019 Sep;22(5):493-499. doi: 10.5223/pghn.2019.22.5.493. Epub 2019 Sep 11.

3.

Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care.

Karampatakis T, Tsergouli K, Iosifidis E, Antachopoulos C, Volakli E, Karyoti A, Sdougka M, Tsakris A, Roilides E.

Microb Drug Resist. 2019 Nov;25(9):1347-1356. doi: 10.1089/mdr.2019.0061. Epub 2019 Jul 31.

PMID:
31364923
4.

Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area.

Karampatakis T, Tsergouli K, Iosifidis E, Antachopoulos C, Mouloudi E, Karyoti A, Tsakris A, Roilides E.

J Glob Antimicrob Resist. 2019 Jun 29;20:214-218. doi: 10.1016/j.jgar.2019.06.019. [Epub ahead of print]

5.

Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit.

Darda VM, Iosifidis E, Antachopoulos C, Volakli E, Haidich AB, Vagdatli E, Sdougka M, Roilides E.

Acta Paediatr. 2019 Oct;108(10):1923-1924. doi: 10.1111/apa.14923. Epub 2019 Jul 30. No abstract available.

PMID:
31265146
6.

Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit.

Karampatakis T, Tsergouli K, Politi L, Diamantopoulou G, Iosifidis E, Antachopoulos C, Karyoti A, Sdougka M, Tsakris A, Roilides E.

Mol Biol Rep. 2019 Jun;46(3):3497-3500. doi: 10.1007/s11033-019-04744-4. Epub 2019 Apr 12.

PMID:
30989561
7.

Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms.

Geladari A, Simitsopoulou M, Antachopoulos C, Roilides E.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02357-18. doi: 10.1128/AAC.02357-18. Print 2019 Mar.

8.

Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit.

Karampatakis T, Tsergouli K, Politi L, Diamantopoulou G, Iosifidis E, Antachopoulos C, Karyoti A, Mouloudi E, Tsakris A, Roilides E.

Microb Drug Resist. 2019 Jun;25(5):712-716. doi: 10.1089/mdr.2018.0266. Epub 2018 Dec 27.

PMID:
30589601
9.

Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria.

Pyrpasopoulou A, Pitsava G, Iosifidis E, Imvrios G, Massa E, Mouloudi E, Goulis I, Chatzidrosou E, Antachopoulos C, Fouzas I, Roilides E.

J Infect. 2018 Nov;77(5):448-454. doi: 10.1016/j.jinf.2018.07.013. Epub 2018 Jul 29. No abstract available.

PMID:
30067946
10.

Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.

Karampatakis T, Tsergouli K, Iosifidis E, Antachopoulos C, Karapanagiotou A, Karyoti A, Gritsi-Gerogianni N, Tsakris A, Roilides E.

J Hosp Infect. 2018 Aug;99(4):396-404. doi: 10.1016/j.jhin.2018.05.010. Epub 2018 May 21.

PMID:
29792971
11.

Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Karampatakis T, Antachopoulos C, Tsakris A, Roilides E.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1211-1220. doi: 10.1007/s10096-018-3244-4. Epub 2018 Apr 11. Review.

PMID:
29644540
12.

Pharmacokinetics of Daptomycin in Critically Ill Pediatric Patients.

Antachopoulos C, Ilia S, Kadiltzoglou P, Baira E, Dokoumetzidis A, Gikas E, Volakli E, Sdougka M, Briassoulis G, Roilides E.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02462-17. doi: 10.1128/AAC.02462-17. Print 2018 Jun.

13.

Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.

Tsekoura M, Ioannidou M, Pana ZD, Haidich AB, Antachopoulos C, Iosifidis E, Kolios G, Roilides E.

Pediatr Infect Dis J. 2019 Jan;38(1):42-49. doi: 10.1097/INF.0000000000002032.

PMID:
29596219
14.

Cluster-distinguishing genotypic and phenotypic diversity of carbapenem-resistant Gram-negative bacteria in solid-organ transplantation patients: a comparative study.

Karampatakis T, Geladari A, Politi L, Antachopoulos C, Iosifidis E, Tsiatsiou O, Karyoti A, Papanikolaou V, Tsakris A, Roilides E.

J Med Microbiol. 2017 Aug;66(8):1158-1169. doi: 10.1099/jmm.0.000541.

PMID:
28758635
15.

Colistin Use in Neonates and Children With Infections Due to Carbapenem-resistant Bacteria.

Antachopoulos C, Iosifidis E.

Pediatr Infect Dis J. 2017 Sep;36(9):905-907. doi: 10.1097/INF.0000000000001655. Review.

PMID:
28650936
16.

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015).

Karampatakis T, Antachopoulos C, Tsakris A, Roilides E.

Future Microbiol. 2017 Jul;12:801-815. doi: 10.2217/fmb-2016-0200. Epub 2017 Jun 12. Review.

PMID:
28604100
17.

Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department.

Geladari A, Karampatakis T, Antachopoulos C, Iosifidis E, Tsiatsiou O, Politi L, Karyoti A, Papanikolaou V, Tsakris A, Roilides E.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12686. Epub 2017 May 5.

PMID:
28251730
18.

A Rare Case of Disseminated Pyogenic Gonococcal Infection in an Immunocompetent Woman.

Romiopoulos I, Pyrpasopoulou A, Varouktsi A, Simoulidou E, Kontopoulou K, Karantani E, Georgopoulou V, Kitsios K, Mamopoulos A, Antachopoulos C, Karagiannis A, Roilides E.

Case Rep Infect Dis. 2016;2016:9629761. doi: 10.1155/2016/9629761. Epub 2016 Dec 27.

19.

A Rare Case of Clavicle Osteomyelitis in a Child and Literature Review.

Chrysochoou EA, Antachopoulos C, Badekas K, Roilides E.

Case Rep Pediatr. 2016;2016:8252318. doi: 10.1155/2016/8252318. Epub 2016 Dec 5.

20.

Comparison of cotrimoxazole vs. second-generation cephalosporins for prevention of urinary tract infections in children.

Antachopoulos C, Ioannidou M, Tratselas A, Iosifidis E, Katragkou A, Kadiltzoglou P, Kollios K, Roilides E.

Pediatr Nephrol. 2016 Dec;31(12):2271-2276. Epub 2016 Aug 15.

PMID:
27525699
21.

Fulminant Epstein-Barr virus-associated hemophagocytic syndrome in a renal transplant patient and review of the literature.

Romiopoulos I, Pyrpasopoulou A, Onoufriadis I, Massa E, Mouloudi E, Kydona C, Giasnetsova T, Gerogianni N, Myserlis G, Solonaki F, Nikodimopoulou M, Mandala E, Antachopoulos C, Roilides E.

Transpl Infect Dis. 2016 Oct;18(5):795-800. doi: 10.1111/tid.12586. Epub 2016 Sep 16. Review.

PMID:
27496079
22.

Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence.

Tsitsopoulos PP, Iosifidis E, Antachopoulos C, Anestis DM, Karantani E, Karyoti A, Papaevangelou G, Kyriazidis E, Roilides E, Tsonidis C.

Acta Neurochir (Wien). 2016 Sep;158(9):1647-54. doi: 10.1007/s00701-016-2890-5. Epub 2016 Jul 25.

PMID:
27452903
23.

Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece.

Karampatakis T, Antachopoulos C, Iosifidis E, Tsakris A, Roilides E.

Future Microbiol. 2016 Jun;11:809-23. doi: 10.2217/fmb-2016-0042. Epub 2016 May 20. Review.

PMID:
27206024
24.

Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria.

Iosifidis E, Violaki A, Michalopoulou E, Volakli E, Diamanti E, Koliouskas D, Antachopoulos C, Drossou-Agakidou V, Sdougka M, Roilides E.

J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):123-128. doi: 10.1093/jpids/piw009. Review.

PMID:
27000866
25.

Isavuconazole: an azole active against mucormycosis.

Roilides E, Antachopoulos C.

Lancet Infect Dis. 2016 Jul;16(7):761-762. doi: 10.1016/S1473-3099(16)00127-4. Epub 2016 Mar 9. No abstract available.

PMID:
26969257
26.

Differential effects of antifungal agents on expression of genes related to formation of Candida albicans biofilms.

Chatzimoschou A, Simitsopoulou M, Antachopoulos C, Walsh TJ, Roilides E.

Mycoses. 2016 Jan;59(1):43-7. doi: 10.1111/myc.12436. Epub 2015 Nov 23.

PMID:
26593284
27.

Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.

Chatzimoschou A, Simitsopoulou M, Antachopoulos C, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2015 Apr;59(4):2198-205. doi: 10.1128/AAC.04934-14. Epub 2015 Feb 2.

28.

In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.

Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2015 Feb;70(2):470-8. doi: 10.1093/jac/dku374. Epub 2014 Oct 6.

29.

Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.

Roilides E, Antachopoulos C, Simitsopoulou M.

Mycoses. 2014 Dec;57 Suppl 3:40-7. doi: 10.1111/myc.12236. Epub 2014 Aug 31. Review.

PMID:
25175306
30.

Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.

Tsiatsiou O, Iosifidis Ε, Katragkou A, Dimou V, Sarafidis K, Karampatakis T, Antachopoulos C, Orfanou A, Tsakris A, Drossou-Agakidou V, Roilides E.

Eur J Pediatr. 2015 Jan;174(1):65-74. doi: 10.1007/s00431-014-2365-8. Epub 2014 Jul 2.

PMID:
24985124
31.

Mannose binding lectin and ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia.

Pana ZD, Samarah F, Papi R, Antachopoulos C, Papageorgiou T, Farmaki E, Hatzipantelis E, Tragiannidis A, Vavatsi-Christaki N, Kyriakidis D, Athanassiadou-Piperopoulou F, Roilides E.

Pediatr Blood Cancer. 2014 Jun;61(6):1017-22. doi: 10.1002/pbc.24951. Epub 2014 Jan 22.

PMID:
24453114
32.

Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine.

Antachopoulos C, Tsolia MN, Tzanakaki G, Xirogianni A, Dedousi O, Markou G, Zografou SM, Eliades A, Kirvassilis F, Kesanopoulos K, Roilides E.

Pediatr Infect Dis J. 2014 Jan;33(1):81-3. doi: 10.1097/INF.0000000000000041.

PMID:
24172850
33.

Renal abscess due to Pseudomonas aeruginosa: report of two cases.

Bampala S, Kollios K, Antachopoulos C, Tratselas A, Roilides E.

Minerva Pediatr. 2013 Jun;65(3):349-52.

PMID:
23685385
34.

30th ESPID annual meeting in Thessaloniki, Greece: three decades of ESPID.

Roilides E, Antachopoulos C.

Pediatr Infect Dis J. 2012 Oct;31(10):1078-9. doi: 10.1097/INF.0b013e31826a81ae. No abstract available.

PMID:
22982950
35.

Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case.

Katragkou A, Antachopoulos C, Hatziagorou E, Sdougka M, Roilides E, Tsanakas J.

Eur J Pediatr. 2013 Apr;172(4):563-7. doi: 10.1007/s00431-012-1811-8. Epub 2012 Aug 21.

PMID:
22907397
36.

Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.

Petraitis V, Petraitiene R, Antachopoulos C, Hughes JE, Cotton MP, Kasai M, Harrington S, Gamaletsou MN, Bacher JD, Kontoyiannis DP, Roilides E, Walsh TJ.

Med Mycol. 2013 Jan;51(1):72-82. doi: 10.3109/13693786.2012.690107. Epub 2012 Jun 11.

PMID:
22686246
37.

Serum levels of daptomycin in pediatric patients.

Antachopoulos C, Iosifidis E, Sarafidis K, Bazoti F, Gikas E, Katragkou A, Drossou-Agakidou V, Roilides E.

Infection. 2012 Aug;40(4):367-71. doi: 10.1007/s15010-011-0240-3. Epub 2012 Jan 21.

PMID:
22271402
38.

Immunotherapy of Cryptococcus infections.

Antachopoulos C, Walsh TJ.

Clin Microbiol Infect. 2012 Feb;18(2):126-33. doi: 10.1111/j.1469-0691.2011.03741.x. Review.

39.

Immunotherapy against invasive mold infections.

Antachopoulos C, Katragkou A, Roilides E.

Immunotherapy. 2012 Jan;4(1):107-20. doi: 10.2217/imt.11.159. Review.

PMID:
22150004
40.

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) due to AIRET16M mutation in a consanguineous Greek girl.

Kollios K, Tsolaki A, Antachopoulos C, Moix I, Morris MA, Papadopoulou M, Roilides E.

J Pediatr Endocrinol Metab. 2011;24(7-8):599-601.

PMID:
21932610
41.

Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.

Chatzimoschou A, Katragkou A, Simitsopoulou M, Antachopoulos C, Georgiadou E, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2011 May;55(5):1968-74. doi: 10.1128/AAC.00959-10. Epub 2011 Feb 22.

42.

Outcome of urinary tract infections caused by extended spectrum β-lactamase-producing Enterobacteriaceae in children.

Tratselas A, Iosifidis E, Ioannidou M, Saoulidis S, Kollios K, Antachopoulos C, Sofianou D, Roilides EJ.

Pediatr Infect Dis J. 2011 Aug;30(8):707-10. doi: 10.1097/INF.0b013e31820d7ec4.

PMID:
21248655
43.

Invasive fungal infections in congenital immunodeficiencies.

Antachopoulos C.

Clin Microbiol Infect. 2010 Sep;16(9):1335-42. doi: 10.1111/j.1469-0691.2010.03289.x. Review.

44.

Ventriculitis caused by Aspergillus fumigatus in a child with central nervous system tuberculosis.

Antachopoulos C, Stergiopoulou T, Simitsopoulou M, Georgiadou E, Kottas S, Marinopoulos D, Anastasiou A, Roilides E.

Mycoses. 2011 Sep;54(5):e627-30. doi: 10.1111/j.1439-0507.2010.01940.x. Epub 2010 Aug 5. No abstract available.

PMID:
20701684
45.

Serum and cerebrospinal fluid levels of colistin in pediatric patients.

Antachopoulos C, Karvanen M, Iosifidis E, Jansson B, Plachouras D, Cars O, Roilides E.

Antimicrob Agents Chemother. 2010 Sep;54(9):3985-7. doi: 10.1128/AAC.01799-09. Epub 2010 Jun 28.

46.

A 5-year epidemiological study of nosocomial bloodstream infections in a neurosurgery department.

Tsitsopoulos PP, Iosifidis E, Antachopoulos C, Tsivitanidou M, Anagnostopoulos I, Roilides E, Tsitsopoulos PD.

Infect Control Hosp Epidemiol. 2010 Apr;31(4):414-7. doi: 10.1086/651310.

PMID:
20184437
47.

Colistin administration to pediatric and neonatal patients.

Iosifidis E, Antachopoulos C, Ioannidou M, Mitroudi M, Sdougka M, Drossou-Agakidou V, Tsivitanidou M, Roilides E.

Eur J Pediatr. 2010 Jul;169(7):867-74. doi: 10.1007/s00431-009-1137-3. Epub 2010 Jan 30.

PMID:
20119725
48.

Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece.

Katsarolis I, Poulakou G, Analitis A, Matthaiopoulou I, Roilides E, Antachopoulos C, Kafetzis DA, Daikos GL, Vorou R, Koubaniou C, Pneumatikos I, Samonis G, Syriopoulou V, Giamarellou H, Kanellakopoulou K.

BMC Infect Dis. 2009 Jul 29;9:120. doi: 10.1186/1471-2334-9-120.

49.

Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi.

Antachopoulos C, Demchok JP, Roilides E, Walsh TJ.

Mycoses. 2010 Jul;53(4):321-8. doi: 10.1111/j.1439-0507.2009.01725.x. Epub 2009 Jul 22.

50.

Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.

Iosifidis E, Antachopoulos C, Tsivitanidou M, Katragkou A, Farmaki E, Tsiakou M, Kyriazi T, Sofianou D, Roilides E.

Infect Control Hosp Epidemiol. 2008 Jul;29(7):615-22. doi: 10.1086/589333.

PMID:
18624668

Supplemental Content

Loading ...
Support Center